Open-Label Extension Study of Voxelotor
An Open-Label Extension Study of Voxelotor Administered Orally to Participants with Sickle Cell Disease Who Have Participated in Voxelotor Clinical Trials
Category & Conditions: Rare Diseases
Medicine: OXBRYTA(VOXELOTOR)
ClinicalTrials.gov Identifier (NCT): NCT04188509
Protocol ID: GBT440-038 (C5341023)
Open Plain Language Summary Result:
Click here